Development of a New Cell Loading System

Information

  • Research Project
  • 6689066
  • ApplicationId
    6689066
  • Core Project Number
    R43HL074493
  • Full Project Number
    1R43HL074493-01
  • Serial Number
    74493
  • FOA Number
  • Sub Project Id
  • Project Start Date
    7/15/2003 - 22 years ago
  • Project End Date
    6/30/2005 - 20 years ago
  • Program Officer Name
    BALDWIN, TIM
  • Budget Start Date
    7/15/2003 - 22 years ago
  • Budget End Date
    6/30/2005 - 20 years ago
  • Fiscal Year
    2003
  • Support Year
    1
  • Suffix
  • Award Notice Date
    7/15/2003 - 22 years ago
Organizations

Development of a New Cell Loading System

DESCRIPTION (provided by applicant): A number of highly potent bioactive compounds and therapeutic agents cannot be used at all, or to the full extent of their potential, because the sites of their action are located within biological cells that restrict access of extracellular drugs to their interior. Examples range from relatively simple, low molecular weight entities which cannot cross the cell membrane due to charge or polarity properties, to macromolecules (including gene constructs) which are cannot gain entry to the cell because of their size and net charge. Although several cell-permeation techniques have been designed, none of them is capable of operating at a high-volume/high-throughput industrial level to satisfy many processing needs throughout the broad realm of biotechnology. To address this continuing need we have invented a new approach to electroporation (EP), which we call "Streaming EP". The basic, and fundamentally different, concept of this approach is as follows: cause cells to flow through a pair of very narrow electrodes, which are connected to a DC voltage source. Each cell will be exposed the electric field for the period of time it spends between the electrodes (analogous to pulse width in existing EP devices). This time equals the product of linear velocity of cell flow and the electrode length in the direction of flow. This approach can overcome the volume/throughput limitation of existing methods while retaining all of the known advantages of electroporation over the other cell-loading techniques. We estimate that streaming EP will be able to process 10-50 milliliters of sample per second (up to 200 liters per hour). In addition, every characteristic feature of electroporation - its capability, portability, low cost, and maintenance-free simplicity - can be substantially enhanced in the streaming EP, making it an extremely attractive new-generation technology. The potential of this technology for biomedical, biodefense and clinical applications is unmatched by any existing process or device.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    95725
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:95725\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    MAXCYTE, INC.
  • Organization Department
  • Organization DUNS
    050740427
  • Organization City
    GAITHERSBURG
  • Organization State
    MD
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    20878
  • Organization District
    UNITED STATES